Our previous clinical study on SULF2 showed that IHC analysis and clinical prognostic follow-up of SULF2 expression in 203 patients with bladder cancer confirmed that SULF2 is highly expressed in bladder cancer and may be associated with lymphatic metastasis, which has clinical significance for evaluating prognosis. The gene discussed is SULF2; the disease is urinary bladder cancer.